B. Purpose of the requirement, Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol Version 6, 08 Jul 2020, MHRA, Medicines & Healthcare products Regulatory Agency
The new requirement was implemented in UK legislation in order to:
1. Enhance the safety of trial subjects/patients by seeking to ensure that the licensing authority is promptly informed of such serious breaches, in order to take appropriate action in response to the breach and/or,
2. To take the information regarding serious breaches into account when assessing future applications for clinical trial authorisation, and applications for marketing authorisation, which include data from trials affected by serious breaches.
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
on demandACROSS Global Training AcademyOnline
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Prochains essais cliniques
-
University of Novi SadRecrutement
-
The First Affiliated Hospital of Zhejiang Chinese...RecrutementRéaction inflammatoire | Syndrome de Tourette chez les enfants | Intolérance alimentaireChine
-
University of Rome G. MarconiUniversity of Bologna; University of the Italian SwitzerlandPas encore de recrutementStresser | Insomnie | Dépression postpartumItalie
-
Selcuk UniversityPas encore de recrutementGamification | Étudiants en soins infirmiers | Multiple Intelligence Theory | Disaster NursingTurquie
-
NuvoAir Medical PCOptum, Inc.Pas encore de recrutementMPOC | Exacerbation de la MPOC | Cardio/Pulm : Insuffisance cardiaque
-
Regeneron PharmaceuticalsIntellia TherapeuticsPas encore de recrutement
-
Centro di Riferimento Oncologico - AvianoRecrutementCancer du poumon non à petites cellules métastatique | Mutation du gène ALKItalie
-
Omphis FoundationRecrutement
-
Institut de cancérologie Strasbourg EuropeContinuum Plus Santé; Plateforme nationale qualité de vie et cancer; WeSharePas encore de recrutementTumeurs mammaires | Tumeurs pulmonaires | Tumeurs prostatiques | Tumeurs colorectalesFrance
-
Al-Balqa Applied UniversityLuzmila HospitalPas encore de recrutement
-
Musculoskeletal Injury Rehabilitation Research...The Geneva Foundation; Uniformed Services University (USU) of the Health Sciences et autres collaborateursPas encore de recrutementThérapie au laser de bas niveau | Thérapie de photobiomodulation | Amélioration de performance | Photomédecine | Quadriceps | Préparation aux opérations spéciales
-
The Seventh Affiliated Hospital of Sun Yat-sen...Huizhou Municipal Central Hospital; Dongguan Hospital of Traditional Chinese... et autres collaborateursRecrutementFracture de l'ostéoporose | Fracture de compression | Ostéoporose Vertébrale | Effectuer un traitement PVP/PKPChine